Peri Tonsillar Infiltration of Ketamine or Bupivacaine for Post Tonsillectomy Analgesia

Phase 4

Completed

• Conditions: Post Operative Pain
• Interventions: Drug: Ketamine.; Drug: Bupivacaine

• Registration Number: NCT05341323
• Lead Sponsor: Sohag University

Brief Summary

Comparison between the analgesic effect of local infiltration of either Bupivacaine or ketamine in the peritonsillar area before the incision of tonsillectomy to achieve postoperative analgesia

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-02
• Study First Submitted: 2022-04-03
• Study First Submitted QC: 2022-04-20
• Study First Posted: 2022-04-22
• Status Verified: 2022-07
• Primary Completion: 2022-07-02
• Study Completion: 2022-07-02
• Last Update Submitted: 2022-07-17
• Last Update Posted: 2022-07-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group K1 Ketamine	Ketamine.	pre-incisional submucosal infiltration of ketamine .5 mg/kg in the Peritonsillar area
Group B1 Bupivacaine	Bupivacaine	pre-incisional submucosal infiltration of Bupivacaine .25 % in the Peritonsillar area

Primary Outcome Measures

Name	Time	Method
Postoperative pain	60 minutes postoperatively	The pain will be assessed using modified Hannallah pain scale which includes blood pressure, movement, agitation and posture where zero is the least pain and 2 is the worest necessitating rescue analgesia

Trial Locations

Locations (1)

Sohag Faculty of Medicine; 🇪🇬 Sohag, Egypt